GlassScriptPhysician profile
Jenny Chien
NPI 1225473507
$1,223.34
in general payments reported to CMS, 2019-2025
13 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2021: $31.54 · 2022: $33.26 · 2023: $208 · 2024: $399 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $718.66 | 2019-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $116.32 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $74.93 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $56.73 | 2024-2025 | Zepbound, Mounjaro |
| Dexcom, INC. | $53.51 | 2022-2024 | Dexcom G6 Transmitter |
| Viiv Healthcare Company | $46.31 | 2024 | Apretude |
| Boston Scientific Corporation | $34.80 | 2019-2021 | |
| Astellas Pharma US INC | $28.54 | 2019-2024 | Veozah |
| Pfizer INC. | $27.91 | 2023-2024 | |
| Exact Sciences Corporation | $20.90 | 2024 | Cologuard Collection Kit |
| Seqirus USA INC | $16.06 | 2024 | Flucelvax, Fluad |
| Biotronik Nro, INC. | $15.79 | 2023 | Biotronik |
| Allergan, INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Chien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.